Table 5.
Control | Digested-Taurisolo® | PMA | PMA + Digested-Taurisolo® | ANOVA | |||
---|---|---|---|---|---|---|---|
T | A | TxA | |||||
COX-2 | 1.00 ± 0.28 a | 1.87 ± 0.33 a | 10.4 ± 4.59 b | 0.54 ± 0.12 a | x | ||
IL-10 | 1.00 ± 0.27 | 8.23 ± 2.34 | 5.25 ± 1.82 | 9.87 ± 4.19 | |||
TNFα | 1.00 ± 0.59 ab | 0.21 ± 0.04 a | 5.32 ± 1.17 c | 2.80 ± 0.86 b | x | x | |
MPO | 1.00 ± 0.21 a | 0.45 ± 0.07 b | 1.25 ± 0.22 b | 0.41 ± 0.05 b | x |
Results are expressed as mean ± SEM, and p < 0.05 was considered statistically significant. Statistical significance was calculated by two-way ANOVA analysis. Factor T (digested-Taurisolo®), Factor A (activation with PMA). Different letters reveal significant differences.